Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

9 questions · 9 findings · 2 reviews · Musculoskeletal

No studies found 2 · 22.2%GRADE not reported 4 · 44.4%Very low 1 · 11.1%Low 1 · 11.1%Moderate 1 · 11.1%High 0 · 0%

Intervention not reported

Adverse events Participants (n) reported serious adverse events · patients with treating osteoarthritis
1 finding from 1 review

Intervention not reported

Adverse events Participants (n) reported serious adverse events · patients with treating osteoarthritis
1 finding from 1 review

Intervention not reported

Adverse events Participants (n) reported serious adverse events · patients with treating osteoarthritis

The review found no eligible studies for this question.

1 finding from 1 review

Intervention not reported

Adverse events Participants (n) reported serious adverse events · patients with osteoarthritis

The intervention showed no clear difference in adverse events Participants (n) reported serious adverse events (moderate certainty).

1 finding from 1 review

Intervention not reported

Adverse events Participants (n) reported serious adverse events · patients with osteoarthritis
1 finding from 1 review

Intervention not reported

Adverse events Participants (n) reported serious adverse events · patients with treating osteoarthritis

The review found no eligible studies for this question.

1 finding from 1 review

Persea gratissma + Glycine max (ASU 300 mg) vs chondroitin sulphate

Adverse events Participants (n) reported serious adverse events · patients with osteoarthritis

Persea gratissma + Glycine max (ASU 300 mg) showed no clear difference in adverse events Participants (n) reported serious adverse events compared with chondroitin sulphate (low certainty).

1 finding from 1 review